86
person
Sébastien Eisinger
staff
Jessica Marshall
Jessica Marshall is an associate at FasterCures.
staff
Nicole Valentine
Nicole Valentine is the director, FinTech at the Milken Institute with over a decade of fina
ncial services, international mergers and acquisitions, technology, and innovation experience.
+ Read More
staff
Christina Dialynas
Christina Dialynas is an associate director at the Milken Institute, Public Health. Prior to join
ing the Center for Public Health, Christina worked on the Milken Institute’s Business and Program Development team as their project manager.
+ Read More
person
Michael Lin, PhD
Dr. Michael Cheng-Yi Lin was a Regional Economist within the Research Department at the Milken In
stitute.
+ Read More
person
Aaron Melaas
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
Best-Performing Cities 2022
Cities continue to drive economic growth across the nation. They are the primary locations where bu
sinesses create new jobs and workers earn higher wages, keeping the United States competitive in the global economy.
+ Read More
report
A Global Early Warning System for Pandemics: A Blueprint for Coordination
The COVID-19 pandemic has had enormous health, social, and economic consequences.
report
Landscape of Trust: Health Data Frameworks
The rapid advancement of the health technology landscape relies heavily on patient data.
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Type 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE
In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley
Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population.
+ Read More